A Small Danish Factory Maker Found a Way to Survive Globalization. The Answer Was to Go Global. When customers told Henrik Hagens his company would be shut out of the Chinese market, he did something bold: he built a factory there. STØVRING, Denmark — The call came during the financial crisis, when most manufacturers were cutting costs, not adding them. A major customer had a blunt message for Henrik Hagens, the owner [...]
This $9 Million Solar Bet Lands Amid an 82% Stock Surge and $3 Billion Revenue Year Sunrun delivers residential solar and battery storage solutions to U.S. homeowners through a direct-to-consumer model.
Century Aluminum CEO Sells 150000 Shares as Aluminum Prices Soar This aluminum producer has been flourishing, and with the metal's price soaring, the company continues to benefit.
Prediction: 2 Things That Will Happen to Alibaba in 2026 Alibaba's e-commerce empire may no longer be the company's biggest growth story. Instead, artificial intelligence and cloud infrastructure are quickly taking center stage.
This Biotech Stock Winner Is Up 72%, but a $4 Million Trim Signals a Slight Reset This clinical-stage biotech develops oncology therapies targeting unmet needs in cancer and immune-mediated conditions.
Ralliant Director Purchases 2350 Shares as Institutional Investors Push for Stock Buyback After a rough Q4 FY 2025 earnings, Ralliant's stock has reached an all-time low. Yet, one of the company's board directors purchased insider shares after the underwhelming earnings.
This $6.5 Million Healthcare Trim Comes Amid a 71% Stock Surge and 20% Revenue Growth This healthcare firm develops advanced surgical solutions for peripheral nerve repair, serving hospitals and specialists worldwide.
Vita Coco CFO Sells 4000 Shares as Stock Sets to Join S&P SmallCap 600 This global beverage company had a strong run in 2025, and now, its stock is set to join one of the top funds in the market.
This $8.9 Million Buy Targets a Stock Down 68% With $322 Million in Cash Biohaven develops clinical-stage therapies for neurological and immunoscience disorders, with no commercialized products to date.
This New $193 Million Bet Targets a Biotech With $689 Million in Revenue and a Potential Turnaround Story This biotech firm develops therapies for rare, complement-driven diseases, with a focus on autoimmune and inflammatory conditions.
This $116 Million Buy Joins a 360% Stock Run and Seemingly Signals Conviction in a Key Drug Launch Cogent Biosciences develops targeted therapies for genetically defined diseases, focusing on precision medicine for rare cancers.
Why Scholastic Stock Climbed This Week The world's largest publisher of children's books is buying back a large swath of its shares.
Why This $18 Million Sale Might Signal a Shift as a China Tech Bet Falls 34% This China-based tech firm links employers and job seekers through its digital recruitment platform serving a broad labor market.
Is Apple Stock Going to $500? Here's What Has to Happen. After an impressive 953% trailing-10-year total return, investors are ready to tackle the next milestone.
Is Micron the Next Nvidia? Micron is experiencing similar sharp revenue growth to Nvidia during the early months following the launch of ChatGPT.
Reddit Stock is Crashing: Is This a Generational Buying Opportunity? Social media companies other than Meta Platforms are struggling to gain investor traction.
This Biotech Was Quietly Bought Before a $58 Per Share Takeout This clinical-stage biotech develops oral therapies targeting cancer and inflammatory diseases, with lead candidates in active trials.
Why Is SoFi Stock Crashing, and Should You Buy the Dip? This financial technology stock is struggling to shift investor sentiment.
Is This Stock a Buy on the Dip? This company has a habit of beating the market over long periods.
High-Flying Biotech Stock Up 360% Faces $48 Million Trim but Remains This Fund's Largest Holding This biotechnology firm develops precision therapies for rare, genetically defined diseases, with a focus on targeted cancer treatments.
Bristow Group's CFO Just Sold $1.2 Million in Stock — But Is That the Whole Equation? Bristow Group, a global aviation services provider to offshore energy firms, reported a notable insider sale in its latest SEC filing.
